全文获取类型
收费全文 | 17129篇 |
免费 | 1366篇 |
国内免费 | 36篇 |
专业分类
耳鼻咽喉 | 160篇 |
儿科学 | 629篇 |
妇产科学 | 495篇 |
基础医学 | 2266篇 |
口腔科学 | 211篇 |
临床医学 | 2562篇 |
内科学 | 2919篇 |
皮肤病学 | 188篇 |
神经病学 | 1921篇 |
特种医学 | 400篇 |
外科学 | 1321篇 |
综合类 | 242篇 |
一般理论 | 37篇 |
预防医学 | 2508篇 |
眼科学 | 377篇 |
药学 | 1002篇 |
中国医学 | 7篇 |
肿瘤学 | 1286篇 |
出版年
2023年 | 118篇 |
2022年 | 59篇 |
2021年 | 333篇 |
2020年 | 230篇 |
2019年 | 366篇 |
2018年 | 424篇 |
2017年 | 319篇 |
2016年 | 343篇 |
2015年 | 420篇 |
2014年 | 564篇 |
2013年 | 875篇 |
2012年 | 1181篇 |
2011年 | 1266篇 |
2010年 | 693篇 |
2009年 | 579篇 |
2008年 | 1116篇 |
2007年 | 1187篇 |
2006年 | 1216篇 |
2005年 | 1157篇 |
2004年 | 1026篇 |
2003年 | 982篇 |
2002年 | 994篇 |
2001年 | 152篇 |
2000年 | 122篇 |
1999年 | 137篇 |
1998年 | 168篇 |
1997年 | 119篇 |
1996年 | 109篇 |
1995年 | 115篇 |
1994年 | 129篇 |
1993年 | 123篇 |
1992年 | 84篇 |
1991年 | 69篇 |
1990年 | 79篇 |
1989年 | 75篇 |
1988年 | 68篇 |
1987年 | 57篇 |
1986年 | 72篇 |
1985年 | 71篇 |
1984年 | 83篇 |
1983年 | 70篇 |
1982年 | 95篇 |
1981年 | 71篇 |
1980年 | 87篇 |
1978年 | 66篇 |
1977年 | 54篇 |
1976年 | 46篇 |
1975年 | 54篇 |
1974年 | 47篇 |
1973年 | 53篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
Rebecca Whear Rebecca A. Abbott Alison Bethel David A. Richards Ruth Garside Emma Cockcroft Heather Iles-Smith Pip A. Logan Ann Marie Rafferty Maggie Shepherd Holly V. R. Sugg Anne Marie Russell Susanne Cruickshank Susannah Tooze GJ Melendez-Torres Jo Thompson Coon 《Journal of advanced nursing》2022,78(1):78-108
5.
Qianlai Luo Jonathan N. Hofmann Ruth M. Pfeiffer Cari M. Kitahara Minkyo Song Meredith S. Shiels 《International journal of cancer. Journal international du cancer》2023,153(1):64-72
In the United States, renal cell carcinoma (RCC) incidence and the prevalence of obesity, an established risk factor for RCC, have been increasing for several decades. RCC is more common among older individuals. We sought to quantify the contribution of excess adiposity to the rising incidence of RCC among individuals 60 years or older. National Institutes of Health-American Association of Retired Persons Diet and Health Study data (n = 453 859 participants, enrolled in 1995-1996, age at enrollment 50-71 years) were used to estimate multivariable-adjusted hazard ratios (HRs) for RCC across body mass index categories and HRs associated with smoking. Population attributable fractions (PAFs) were calculated using estimated HRs and annual overweight/obesity prevalence from the National Health Interview Survey (1985-2008). PAF estimates were combined with RCC incidence from Surveillance, Epidemiology and End Results-13 to calculate annual percent changes in RCC incidence attributable (and unrelated) to overweight/obesity. We found that between 1995 and 2018, among individuals aged 60 years and older, PAF for overweight/obesity increased from 18% to 29% for all RCCs. In comparison, the PAF for smoking declined from 12% to 9%. RCC incidence increased 1.8% per year (95% confidence interval [CI] 1.5%-2.1%) overall, while RCC incidence attributable to overweight/obesity increased 3.8% per year (95%CI 3.5%-4.2%) and RCC incidence unrelated to overweight/obesity increased 1.2% per year (95% CI 0.9%-1.4%). In conclusion, overweight/obesity appears to have contributed importantly to the rising incidence of RCC in the United States since the mid-1990s. Public health interventions focused on reducing overweight and obesity could help substantially in curbing this trend. 相似文献
6.
7.
Mei Yin Wong Katrina A. Andrews Benjamin G. Challis Soo‐Mi Park Carlo L. Acerini Eamonn R. Maher Ruth T. Casey 《Clinical endocrinology》2019,90(4):499-505
The succinate dehydrogenase (SDH) enzyme complex functions as a key enzyme coupling the oxidation of succinate to fumarate in the citric acid cycle. Inactivation of this enzyme complex results in the cellular accumulation of the oncometabolite succinate, which is postulated to be a key driver in tumorigenesis. Succinate accumulation inhibits 2‐oxoglutarate‐dependent dioxygenases, including DNA and histone demethylase enzymes and hypoxic gene response regulators. Biallelic inactivation (typically resulting from one inherited and one somatic event) at one of the four genes encoding the SDH complex (SDHA/B/C/D) is the most common cause for SDH deficient (dSDH) tumours. Germline mutations in the SDHx genes predispose to a spectrum of tumours including phaeochromocytoma and paraganglioma (PPGL), wild type gastrointestinal stromal tumours (wtGIST) and, less commonly, renal cell carcinoma and pituitary tumours. Furthermore, mutations in the SDHx genes, particularly SDHB, predispose to a higher risk of malignant PPGL, which is associated with a 5‐year mortality of 50%. There is general agreement that biochemical and imaging surveillance should be offered to asymptomatic carriers of SDHx gene mutations in the expectation that this will reduce the morbidity and mortality associated with dSDH tumours. However, there is no consensus on when and how surveillance should be performed in children and young adults. Here, we address the question: “What age should clinical, biochemical and radiological surveillance for PPGL be initiated in paediatric SDHx mutation carriers?”. 相似文献
8.
9.
10.
Ans Van Ginckel Ruth Wittoek Sophie De Mits Patrick Calders 《Arthritis care & research》2019,71(10):1372-1378